Implantica AG (FRA:8IM1)

Market Cap	1.10B +27.6%
Revenue (ttm)	2.07M +7.1%
Net Income	-19.63M
EPS	-0.07
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	5
Open	3.790
Previous Close	3.695
Day's Range	3.790 - 3.790
52-Week Range	2.250 - 7.540
Beta	n/a
RSI	43.83
Earnings Date	May 8, 2026

About Implantica AG

Implantica AG engages in the research and distribution of medical implants in Switzerland. The company’s lead product candidate is RefluxStop, a passive CE-marked implant for prevention of gastroesophageal reflux disease. It focuses on two treatment areas, Gastrointestinal surgery and Urology. It is also involved in the development of eHealth platform, a digital health system to support its pipeline of smart medical implants designed for a safe and secure control and monitoring over the internet; e-InVivo, a sensor implants to monitor a multitu...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2015
• Country: Liechtenstein
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 8IM1

Financial Performance

In 2025, Implantica AG's revenue was 2.07 million, an increase of 7.08% compared to the previous year's 1.94 million. Losses were -19.63 million, -15.89% less than in 2024.